Ash Access Technology's New Flagship Product Name Created by Strategic Name Development.MINNEAPOLIS -- Zuragen[TM], a novel, injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. antimicrobial/antithrombotic therapy from Ash Access Technology, Inc. was named by Strategic Name Development, a brand name consultancy that develops product names, company names, taglines and conducts brand name research. Zuragen[TM] is being developed for the prevention and treatment of catheter related bloodstream infection (CRBSI) in patients requiring the use of a central venous catheter central venous catheter n. A catheter passed through a peripheral vein and ending in the thoracic vena cava; it is used to measure venous pressure or to infuse concentrated solutions. . In pre-clinical studies, Zuragen[TM] has demonstrated significant and rapid broad-spectrum antimicrobial efficacy as well as the elimination of biofilm Biofilm An adhesive substance, the glycocalyx, and the bacterial community which it envelops at the interface of a liquid and a surface. When a liquid is in contact with an inert surface, any bacteria within the liquid are attracted to the surface and adhere - a safe haven 1. Designated area(s) to which noncombatants of the United States Government's responsibility and commercial vehicles and materiel may be evacuated during a domestic or other valid emergency. 2. for bacteria. In addition, the company will be looking to show that Zuragen(TM) is non-inferior to heparin (today's de facto standard Hardware or software that is widely used, but not endorsed by a standards organization. Contrast with de jure standard. de facto standard - A widespread consensus on a particular product or protocol which has not been ratified by any official standards body, such as ISO, of care) in terms of providing patency pa·ten·cy n. The state or quality of being open, expanded, or unblocked. patency the condition of being open. for central venous catheters. Ash Access Technology initiated patient enrollment for the AZEPTIC (Analysis of Zuragen's Efficacy in the Prevention and Treatment of Catheter Infections) trial in August of 2006. Enrollment is expected to be completed this year. "Zuragen(TM) is an exciting technology that addresses a significant unmet medical need and has the potential to be used across a wide range of patient populations," said Bob Truitt, President of Ash Access Technology. "In working with Strategic Name Development, we were able to develop a name that both defines our product's unique attributes and captures the excitement of technological innovation." "It is an honor to work with Ash Access Technology because of its heritage and its commitment to combat deadly infection," said William Lozito, President of Strategic Name Development. "We are thrilled with the outcome of a collaborative name development process that resulted in a mellifluous mel·lif·lu·ous adj. 1. Flowing with sweetness or honey. 2. Smooth and sweet: "polite and cordial, with a mellifluous, well-educated voice" H.W. Crocker III. combination of the familiar Latin and Greek roots, Zur- for the azure blue Azure Blue is a fictional character who was created by Carl Barks for The Walt Disney Company. He first appeared as an evil miser in The Golden Helmet in Donald Duck Four Color #308. color of the product, and Gen- for the pathogen eradication it performs." About Ash Access Technology, Inc. Ash Access Technology, Inc., founded in 2003, is an integrated specialty pharmaceutical / medical device company engaged in the development and commercialization of proprietary therapies and devices to prevent and treat complications related to vascular access vascular access Clinical medicine The ability to enter the vascular system; the ease with which the vascular system can be entered for administering therapy or obtaining blood for testing . The company has an advanced portfolio of innovative products targeting catheter-related bloodstream infections (CRBSI), biofilm elimination and poor patency (blood flow) - the significant challenges associated with the use of vascular access devices. For more information about Zuragen[TM] and Ash Access Technology Inc., please visit www.ashaccess.com. About Strategic Name Development, Inc. Strategic Name Development, Inc., partners with companies to develop product names, company names, taglines and to conduct brand name research. The brand name consultancy combines the three forces of linguistics, creativity and target-market research to build brand names that are instantly recognizable, memorable and strategically sound. For more information about Strategic Name Development, please visit www.namedevelopment.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion